
Saturday, June 08, 2024, 6:00 PM 11:00 PM
The Beverly Hilton 9876 Wilshire Blvd.
Beverly Hills, California 90210
Since 1899, National Jewish Health has served as a beacon of hope for millions of children and adults worldwide who suffer from heart, lung, immune and related diseases. Through our multidisciplinary approach, world-class physicians and researchers collaborate across specialties, enabling them to make the correct diagnosis the first time.
As the leading respiratory hospital in the nation, people come from across the country and around the world to our main campus, our 25 locations across Colorado, and our Respiratory Institutes® in Denver, New York and Philadelphia for our unsurpassed excellence in patient care and research.
Throughout our history, National Jewish Health researchers have made numerous groundbreaking discoveries, including IgE, the molecule responsible for allergic reactions; the T-cell receptor gene, which triggers an immune response; the genetic roots of pulmonary fibrosis (scarring in the lungs); and more.
Clinical research at National Jewish Health has contributed to important new treatments for pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), asthma and others.
We treat all patients, regardless of ability to pay, and in fiscal year 2023, we provided nearly $43 million in charity and subsidized care to patients from across the country.
National Jewish Health is also the only medical campus in the country with a school for chronically ill children. Morgridge Academy is a free K-8 school for children diagnosed with diseases, including severe asthma and allergies, cystic fibrosis and immune deficiencies, including HIV/AIDS.
This level of excellence in patient care and research goes beyond the walls of National Jewish Health.
Whether you live in Denver, Los Angeles, New York or London, our research benefits you and your family — even if you never come here for care.